908 Devices (MASS) Registration Filing summary

Company overview and business model

• Develops handheld devices for point-of-need chemical and biochemical analysis using proprietary mass spectrometry and optical spectroscopy technologies.

• Devices are designed to be smaller, more accessible, and easier to operate than conventional laboratory instruments.

• Applications include health and safety, such as drug detection, toxic exposure, and security threats.

• Incorporated in Delaware in 2012 and operates as a smaller reporting company under SEC regulations.

Use of proceeds and capital allocation

• Net proceeds from securities sales will be used for working capital and general corporate purposes.

• Management retains broad discretion over the allocation of proceeds.

Risk factors and disclosures

• Investment involves a high degree of risk, including potential harm to business, financial condition, and results of operations.

• Risks include market acceptance, competition, ability to hire and retain personnel, regulatory effects, and volatility of stock price.

• Forward-looking statements are subject to significant uncertainties and actual results may differ materially.